Categories Uncategorized

United Medical Equipment Business Solutions Network Inc. Stands Out As Trusted Supplier of Life Saving Personal Protective Equipment

  • With demand for PPE exploding virtually overnight due to the pandemic, PPE-related fraud involving counterfeit or faulty equipment surged
  • As a reliable source of everything PPE-related, UME has established itself as a go-to provider of premier equipment that can be trusted 
  • The company pivoted its business model when the pandemic started to seize growing market opportunity and provide reliable, high-quality PPE essentials amid the virus outbreak

United Medical Equipment Business Solutions Network (“UME”) (“UMEBSNI”), the distributor of a comprehensive line of COVID-19 products, stands out as a trusted source of reliable and authentic personal protective equipment (“PPE”) supplies. The SARS-CoV-2 virus is mainly transmitted by inhalation of respiratory droplets, but in poorly ventilated indoor settings, aerosol transmission may also happen. For this reason, gowns, gloves, eye protection and an N95 or equivalent respirator are needed, especially in the healthcare environment. Indispensable for health care professionals caring for patients with SARS-CoV-2, PPE equipment is a lifeline (https://ibn.fm/TrStJ). When used appropriately, it considerably reduces the risk of viral transmission, so it has become a fundamental component of infection prevention and control measures. 

But, not all PPE is created equal. As the virus spread around the country, an immediate and drastic need for personal protective equipment exploded. This soaring demand for PPE was quickly accompanied by the PPE-related fraud, which called for an increase in federal scrutiny to combat the fraudulent attempts. 

PPE fraud involves a broad range of fraudulent activities, from the selling of counterfeit or faulty testing kits, surgical gowns, gloves, facial masks and cleaning products to making false or misleading claims about the effectiveness of the product. Some fraudsters offer to provide respiratory masks or medical devices never intended to be delivered, or they deliver those of lesser quality than advertised. PPE equipment that is not working as advertised means that it does not function or does not provide the necessary protection (https://ibn.fm/PMNGZ). That is why it is critical to secure a trusted supplier of personal protection equipment. 

As a trusted supplier of FDA-approved COVID-19 rapid antibody test kits and PPE equipment, UME stands out in this environment where buyers can potentially fall prey to those selling counterfeit or faulty equipment. In this pandemic where adequate PPE equipment is critical for saving lives, UME is committed to differentiating itself as a premier provider of vital PPE products, delivering affordable and dependable PPE and other crucial medical supplies and durable medical equipment. The company partners with manufacturers worldwide to provide lifesaving PPE, including nitrile gloves, protective gowns, face shields and more. Its N-95 and KN-95 protective masks— considered to provide the highest level of protection — are made in the USA.  

The company was a third-party referral source for seniors and a medical supplier before the pandemic. As the demand for PPE equipment exploded due to the virus outbreak, the company was quick to pivot, shifting the business model and become the dependable source of everything PPE-related. UME has quickly grown into a trusted go-to provider of personal protective equipment, syringes and test kits offering a post-pandemic staple including hand sanitizers, gloves, face shields, masks, gowns and hoods (https://ibn.fm/LjKfL). In a world riddled with knockoffs, UME appears to offer reliability and peace of mind when it comes to equipment that saves lives. 

For more information, visit the company’s website at www.UnitedMedSolutions.com

NOTE TO INVESTORS: The latest news and updates relating to United Medical Equipment are available in the company’s newsroom at https://ibn.fm/UnitedMed 

About BioMedWire

BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.

To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information, please visit https://www.biomedwire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer

BioMedWire (BMW)
San Francisco, California
www.biomedwire.com
415.949.5050 Office
Editor@BioMedWire.com

BioMedWire is part of the InvestorBrandNetwork.

Chris@BMW

Share
Published by
Chris@BMW

Recent Posts

Earth Science Tech Inc. (ETST) Builds Telehealth, Pharmacy Links in Evolving Digital Care

Patients increasingly prefer access, speed and convenience, but healthcare systems also need better coordination, safer…

15 hours ago

Soligenix Inc. (NASDAQ: SNGX) Advances Rare Disease Innovation Through Platform Science and Expanding Therapeutic Pipeline

High-quality development platforms and translational research frameworks have become essential tools in rare-disease biotechnology. Soligenix…

17 hours ago

Mirror-Image Amino Acid Shows Promise in Starving Cancer Cells

Most existing cancer treatments not only attack cancer cells but also adversely impact healthy body cells. The…

2 days ago

Investing in Innovation: Evaluating the Clinical and Commercial Potential of LB-100 and Liora’s Proton Therapy

LIXTE Biotechnology Holdings and Liora Technologies recently joined forces to soon offer a real fight…

3 days ago

Microbial Ecosystems Play a Big Role in the Efficacy of Cancer Immunotherapy

Significant strides have been made in leveraging checkpoint inhibitor therapy to combat a number of cancers over the recent…

6 days ago

LIXTE Biotechnology Holdings Inc. (NASDAQ: LIXT) Expands LB 100 Development Through Strategic Academic and Pharma Partnerships

LIXTE recently expanded its ovarian clear cell cancer trial in partnership with MD Anderson and…

6 days ago